A 73-Year-Old Male With Mantle Cell Lymphoma

Brian Hill, MD, reviews the case of a 73-year-old man with mantle cell lymphoma and discusses the latest data and treatment approaches.

EP. 1: 73-Year-Old Man With Mantle Cell Lymphoma

January 25th 2021

Brian Hill, MD, reviews the case of a 73-year-old man with mantle cell lymphoma.

EP. 2: Frontline Treatment Options in Mantle Cell Lymphoma

January 25th 2021

Brian Hill, MD, reviews frontline treatment options for patients with mantle cell lymphoma.

EP. 3: Second-Line Treatment Options in Mantle Cell Lymphoma

January 25th 2021

Brian Hill, MD, reviews second-line treatment options for patients with relapsed/refractory mantle cell lymphoma.

EP. 4: Results of the ZUMA-2 Trial in Relapsed/Refractory Mantle Cell Lymphoma

January 25th 2021

Brian Hill, MD, reviews practice-changing data from the ZUMA-2 trial in patients with relapsed/refractory mantle cell lymphoma.

EP. 5: Mitigating CAR T–Related Toxicities in Mantle Cell Lymphoma

January 25th 2021

Brian Hill, MD, reviews strategies for mitigating toxicities associated with CAR T-cell therapy.

EP. 6: Role of CAR T-cell Therapy in Mantle Cell Lymphoma

January 25th 2021

Brian Hill, MD, reviews the role of CAR T-cell therapy in mantle cell lymphoma.

EP. 7: Unmet Needs and Future Directions in Mantle Cell Lymphoma

January 25th 2021

Brian Hill, MD, reviews unmet needs and future directions in the management of mantle cell lymphoma.